Using A Natural DNA Repair Process to Improve Genetic Medicines
RARECast - Un podcast de RARECast - Les jeudis
Catégories:
Daniel Gruskin, chief medical officer of LogicBio, discusses the company’s platform technology, the advantages it provides, and the company’s lead experimental therapy for the rare metabolic condition methylmalonic acidemia.
